海创药业-U
(688302)
| 流通市值：44.65亿 | | | 总市值：54.23亿 |
| 流通股本：8151.51万 | | | 总股本：9901.56万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 13,167,136.01 | - | 366,836.28 | 109,734.51 |
| 营业收入 | 13,167,136.01 | - | 366,836.28 | 109,734.51 |
| 二、营业总成本 | 85,364,215.91 | 36,727,239.36 | 217,539,778.96 | 167,129,902.63 |
| 营业成本 | 62,643.88 | - | 335,918 | 96,520.22 |
| 税金及附加 | 376,732.29 | 86,848.79 | 411,284.78 | 335,459.57 |
| 销售费用 | 10,500,524.53 | 3,901,495.5 | 11,353,420.85 | 8,060,379.44 |
| 管理费用 | 21,421,965.73 | 10,121,852.82 | 42,140,341.42 | 31,408,401.17 |
| 研发费用 | 56,967,171.91 | 24,765,858.75 | 174,031,725.15 | 133,308,299.09 |
| 财务费用 | -3,964,822.43 | -2,148,816.5 | -10,732,911.24 | -6,079,156.86 |
| 其中:利息费用 | 195,045.1 | 205,515.51 | 526,607.32 | 386,144.54 |
| 其中:利息收入 | 4,571,463.99 | 2,456,849.16 | 10,013,732.89 | 7,707,333.76 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,054,220.43 | 1,535,554.13 | 3,962,834.76 | 3,476,139.91 |
| 加:投资收益 | 1,843,351.3 | 1,920,474.11 | 9,144,656.32 | 6,944,387.25 |
| 信用减值损失(新) | -806,540.25 | -731,402.59 | -324,710.27 | -313,071.13 |
| 其他收益 | 7,494,467.56 | 1,902,857.49 | 4,908,617.33 | 2,852,236.87 |
| 四、营业利润 | -61,611,580.86 | -32,099,756.22 | -199,481,544.54 | -154,060,475.22 |
| 加:营业外收入 | - | - | 110 | 1.75 |
| 减:营业外支出 | 239,605.3 | - | 2,073.6 | 2,072.96 |
| 五、利润总额 | -61,851,186.16 | -32,099,756.22 | -199,483,508.14 | -154,062,546.43 |
| 减:所得税费用 | 2,014.8 | 2,012.55 | 12,227.96 | 8,886.5 |
| 六、净利润 | -61,853,200.96 | -32,101,768.77 | -199,495,736.1 | -154,071,432.93 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -61,853,200.96 | -32,101,768.77 | -199,495,736.1 | -154,071,432.93 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -61,853,200.96 | -32,101,768.77 | -199,495,736.1 | -154,071,432.93 |
| 扣除非经常损益后的净利润 | -73,005,634.95 | -37,460,654.5 | -217,509,880.91 | -167,342,125.75 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.62 | -0.32 | -2.01 | -1.56 |
| 八、其他综合收益 | -39,554.47 | -12,510.77 | -139,265.41 | -50,937.38 |
| 归属于母公司股东的其他综合收益 | -39,554.47 | -12,510.77 | -139,265.41 | -50,937.38 |
| 九、综合收益总额 | -61,892,755.43 | -32,114,279.54 | -199,635,001.51 | -154,122,370.31 |
| 归属于母公司股东的综合收益总额 | -61,892,755.43 | -32,114,279.54 | -199,635,001.51 | -154,122,370.31 |
| 公告日期 | 2025-08-14 | 2025-04-26 | 2025-04-19 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |